Dhanwantari Therapeutics Private Limited
Conducts research and development services in chemistry since 2008.
2008 | Rangareddy, Telangana (India) | Active
Dhanwantari Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 2.27%
- Profit Growth 3.22%
- Ebitda 124.32%
- Net Worth 12.17%
- Total Assets 1.42%
About Dhanwantari Therapeutics
Dhanwantari Therapeutics Private Limited (DTPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2008 and has a history of 17 years and one month. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kamalakara Pantangi and Jayasree Pantangi serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100TG2008PTC058165
- Company No.
058165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Dhanwantari Therapeutics Private Limited
Explore comprehensive data for Dhanwantari Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Dhanwantari Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamalakara Pantangi  | Director | 14-Mar-2008 | Current |
| Jayasree Pantangi | Director | 14-Mar-2008 | Current |
Financial Performance of Dhanwantari Therapeutics.
Dhanwantari Therapeutics Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.27% increase. The company also saw a slight improvement in profitability, with a 3.22% increase in profit. The company's net worth Soared by an impressive increase of 12.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanwantari Therapeutics?
In 2017, Dhanwantari Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sree Raghavendra Hospitals Pvt LtdKamalakara Pantangi and Jayasree Pantangi are mutual person
- Dfi Publications Private Limited
Kamalakara Pantangi and Jayasree Pantangi are mutual person
- Dfi Television Private Limited
Kamalakara Pantangi is a mutual person
- Sree Siva Raghavendra Remedies Private Limited
Kamalakara Pantangi is a mutual person
- Dfi Nirmaan Private Limited
Kamalakara Pantangi and Jayasree Pantangi are mutual person
- Dfi Ventures Limited
Kamalakara Pantangi and Jayasree Pantangi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dhanwantari Therapeutics?
Unlock and access historical data on people associated with Dhanwantari Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanwantari Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantari Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Dhanwantari Therapeutics
Recent activity within the organization
- Annual General Meeting
Dhanwantari Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Dhanwantari Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Kamalakara Sharma Pantangi was appointed as a Director was appointed as a Director on 14 Mar 2008 & has been associated with this company since 17 years 1 month .
- Director Appointment
Jayasree Sarma Pantangi was appointed as a Director was appointed as a Director on 14 Mar 2008 & has been associated with this company since 17 years 1 month .
- Company Incorporation
Dhanwantari Therapeutics Private Limited was registered on 14 Mar 2008 with Roc Hyderabad & aged 17 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Dhanwantari Therapeutics Private Limited?
Dhanwantari Therapeutics Private Limited was incorporated on 14 Mar 2008.
What is authorized share capital and paid-up capital of Dhanwantari Therapeutics Private Limited?
The authorized share capital of Dhanwantari Therapeutics Private Limited is ₹ 2.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Dhanwantari Therapeutics Private Limited?
Currently 2 directors are associated with Dhanwantari Therapeutics Private Limited.
- Kamalakara Sharma Pantangi
- Jayasree Sarma Pantangi
What is the registered address of Dhanwantari Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Dhanwantari Therapeutics Private Limited is 8-1-206/A Raghavendra Hills Mylardevpally Near Kattedan, Rajendranagar Mandal India, Hyderabad, Telangana, 500005.
What is the corporate identification number (CIN) and company number of Dhanwantari Therapeutics Private Limited?
The corporate identification number (CIN) of Dhanwantari Therapeutics Private Limited is U24100TG2008PTC058165 and the company number is 058165 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Dhanwantari Therapeutics Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Dhanwantari Therapeutics Private Limited has risen by 2.27%.
What change has been observed in the net worth of Dhanwantari Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Dhanwantari Therapeutics Private Limited has experienced an upsurge of 12.17%.
When was the last Balance Sheet of Dhanwantari Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Dhanwantari Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records